Fresenius SE & Co KGaA Share Price OTC Bulletin Board
Equities
FSNUF
DE0005785604
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
03/05 | European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower | MT |
03/05 | FRESENIUS SE : Buy rating from Barclays | ZD |
Sales 2024 * | 22.96B 24.71B 2,061B | Sales 2025 * | 24.06B 25.89B 2,160B | Capitalization | 15.74B 16.94B 1,413B |
---|---|---|---|---|---|
Net income 2024 * | 1.45B 1.56B 130B | Net income 2025 * | 1.78B 1.92B 160B | EV / Sales 2024 * | 1.31 x |
Net Debt 2024 * | 14.27B 15.36B 1,281B | Net Debt 2025 * | 13.48B 14.51B 1,210B | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
8.78
x | Employees | - |
Yield 2024 * |
3.34% | Yield 2025 * |
3.79% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 12/21/12 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 01/19/01 |
Michael Moser
CMP | Compliance Officer | - | 18/23/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 20/15/20 |
Wolfgang Kirsch
CHM | Chairman | 69 | 01/20/01 |
Konrad Kölbl
BRD | Director/Board Member | 64 | 16/07/16 |
1st Jan change | Capi. | |
---|---|---|
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
+28.34% | 11.79B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- FRE Stock
- FSNUF Stock